Comment: CDC should be clear about monkeypox vaccine’s limits

Health officials don’t have recent data on Jynneos’ effectiveness in preventing infections and what precautions are necessary.

By Lisa Jarvis / Bloomberg Opinion

As U.S. public health authorities deploy a new strategy to expand access to the monkeypox vaccine, they need to be more clear and open about exactly what protection the shots can provide.

The Food and Drug Administration this week issued emergency authorization to administer a small dose of Bavarian Nordic’s Jynneos vaccine — one-fifth the usual size — within the skin, or intradermally, rather than under the skin. About 440,000 of the 600,000 recently allocated doses of Jynneos remain, an official from the Department of Health and Human Services explained, and the new strategy will stretch that supply into 2.2 million shots.

In making this change, the FDA is relying on a 2015 study showing that the two methods of administration elicit a similar immune response in healthy adults. Unfortunately, that study provides no information about effectiveness of either approach.

ADVERTISEMENT
0 seconds of 0 secondsVolume 0%
Press shift question mark to access a list of keyboard shortcuts
00:00
00:00
00:00
 

Neither does the statistic so often cited, including by the World Health Organization, that the vaccine is effective at preventing 85 percent of monkeypox infections. That figure is based on data collected in Africa in the 1980s, when an older monkeypox vaccine (one that elicits a similar immune response) was used and the primary form of transmission was either animal or household exposure.

These immunological studies give public health experts confidence that the vaccine protects against the most severe cases of monkeypox, but no clinical data exist to show whether it stops transmission, prevents the painful lesions seen in most cases, or provides lifelong protection of any kind.

Until such data are gathered, public health officials need to be clear about what they don’t know; especially when speaking to people considered at highest risk in the current outbreak, gay and bisexual men.

Right now, the biggest concern is communicating the risk of infection after vaccination. “How do we accurately message to right now mostly men what their risk is after being fully vaccinated?” said Jay Varma, a professor of population health sciences at Weill Cornell Medicine, in New York City.

We’ve seen this movie before. In the summer of 2021, Moderna’s and Pfizer’s covid vaccines appeared to prevent not just the most serious cases of disease but also infection. Vaccinated people were told they could feel safe gathering indoors, without masks; that the country was heading toward “normal.” Then came the wave of breakthrough infections.

Infectious-disease experts, including Varma, who served as New York City Mayor Bill de Blasio’s senior adviser for public health, “got a little bit ahead of our skis,” he said. That bred confusion about what activities were actually safe, and ultimately undermined confidence in the covid vaccines.

Communicating the value of vaccines is a balancing act. People need accurate information about how safe shots are and exactly what protection they provide. Unknowns and nuances need to be shared so people can make their own best lifestyle decisions after vaccination. The goal should be to encourage vaccination but not exaggerate its benefits.

Messaging about Jynneos has been further muddied by efforts in some cities to stretch limited vaccine supplies by offering people one shot instead of two. While that gets more shots in arms faster, the danger is that men might feel safe to resume sexual activity without actually having sufficient protection from the monkeypox virus.

Rochelle Walensky, director of the Centers for Disease Control and Prevention, this week reiterated the recommendation that people take steps to protect themselves from exposure to the virus, especially if they have had only one shot, “because we don’t yet know how well these vaccines work.”

The CDC has been working on several vaccine effectiveness projects that will gather data from both on-the-ground investigations and formal clinical trials, she said. The agency expects to have initial estimates of vaccine effectiveness soon. The National Institutes of Health is also mapping out its own studies.

During the pandemic, people in the LGBTQ community — and men in particular — had higher levels of covid vaccination than heterosexual adults. The CDC and FDA should now do everything possible to support that commitment to personal and public health by providing clear communication about the monkeypox vaccine.

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Opinion

toon
Editorial cartoons for Wednesday, May 21

A sketchy look at the news of the day.… Continue reading

A visitor takes in the view of Twin Lakes from a second floor unit at Housing Hope’s Twin Lakes Landing II Wednesday, Feb. 22, 2023, in Marysville, Washington. (Ryan Berry / The Herald)
Editorial: Housing Hope’s ‘Stone Soup’ recipe for community

With homelessness growing among seniors, an advocate calls for support of the nonprofit’s projects.

Burke: Don’t let Trump & Co. get away with ‘no comment’ on outrages

For the tiring list of firings, cuts, busted norms and unconstitutional acts, hold them accountable.

Opposition to amendment to habitat rules ignored

The article regarding Snohomish County’s habitat ordiance reports a preponderance of Snohomish… Continue reading

DIYers should get a PUD’s heat-pump break, too

I have just completed a do-it-yourself installation of a central heat pump… Continue reading

Everett Council, Dist. 2: Paula Rhyne has proved herself

Four years ago, a public servant ran for District 2 and won… Continue reading

Comment: Era of Buffett-, Gates-style philanthropy is ending

The tech billionaires see their space and AI quests as better than a bequest to fight poverty and disease.

toon
Editorial cartoons for Tuesday, May 20

A sketchy look at the news of the day.… Continue reading

Douthat: What guides Trump policy is a doctorine of the deal

Hawk or dove, former friend or foe; what matters most is driving a bargain, for good or ill.

Friedman: The uncertainties facing Biden and the world order

Biden, facing infirmities of mind and body, still understands the mission of America in the world.

Comment: GOP’s tax cut bill is ill-timed for economic moment

If a recession does hit, it’s the lower- and middle-income who can spend the economy’s way out; not the rich.

Comment: AmeriCorps staffers were making America healthy again

A modest stipend for students was providing experience and value. Until the Trump administration fired them.

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.